Lipocine Inc. 4
4 · Lipocine Inc. · Filed Jun 15, 2015
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Mattila Jyrki
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-06-11+10,000→ 90,000 totalExercise: $7.32Exp: 2025-06-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary date of June 11, 2016, with the remaining 2/3 of the shares vesting monthly on a pro-rata basis over the following two years.